Caffeine for treatment of Parkinson disease: a randomized controlled trial.

Neurology2012Postuma RB, Lang AE, Munhoz RP, et al.

Study designRandomized controlled trial

SubjectHuman

Record checks

Study design: Randomized controlled trial
Subject: Human
Publication year: 2012
Source: doi.org
Abstract display: Not reproduced here
Publication status: Corrected
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Publication-status notice

Publication status: Corrected

Europe PMC relationship metadata: corrected_by.

View status evidence →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AgedAged, 80 and overCaffeineCentral Nervous System StimulantsFatigueFemaleHumansMaleMiddle AgedParkinson DiseaseQuality of LifeSeverity of Illness IndexTreatment Outcome

DOI 10.1212/wnl.0b013e318263570d

PMID 22855866

View source →